HDACi protects against vascular cognitive impairment from CCH injury via induction of BDNF‐related AMPA receptor activation

We previously showed a hydroxamic acid‐based histone deacetylase inhibitor (HDACi), compound 13, provides neuroprotection against chronic cerebral hypoperfusion (CCH) both in vitro under oxygen‐glucose deprivation (OGD) conditions and in vivo under bilateral common carotid artery occlusion (BCCAO) c...

Descripción completa

Detalles Bibliográficos
Autores principales: Fang, Yao‐Ching, Hsieh, Jia‐Yu, Vidyanti, Amelia Nur, Yang, Chih‐Hao, Jan, Jing‐Shiun, Chang, Kang‐Wei, Hu, Chaur‐Jong, Tu, Yong‐Kwang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8335662/
https://www.ncbi.nlm.nih.gov/pubmed/34216182
http://dx.doi.org/10.1111/jcmm.16770

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8335662/
https://www.ncbi.nlm.nih.gov/pubmed/34216182
http://dx.doi.org/10.1111/jcmm.16770

Ejemplares similares